GoHealth, Inc.
GOCO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $34 | $94 | $221 | $389 |
| % Growth | -63.7% | -57.4% | -43.2% | – |
| Cost of Goods Sold | $20 | $32 | $24 | $52 |
| Gross Profit | $14 | $62 | $197 | $337 |
| % Margin | 41.2% | 65.5% | 89.4% | 86.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $28 | $22 | $23 | $32 |
| SG&A Expenses | $45 | $50 | $90 | $131 |
| Sales & Mktg Exp. | $17 | $28 | $67 | $100 |
| Other Operating Expenses | $257 | $111 | $101 | $125 |
| Operating Expenses | $302 | $161 | $191 | $257 |
| Operating Income | -$288 | -$99 | $7 | $80 |
| % Margin | -842.2% | -105.7% | 3% | 20.6% |
| Other Income/Exp. Net | -$26 | -$17 | -$15 | -$20 |
| Pre-Tax Income | -$314 | -$116 | -$9 | $60 |
| Tax Expense | -$0 | -$0 | $1 | $2 |
| Net Income | -$166 | -$54 | -$4 | $26 |
| % Margin | -485.1% | -57.7% | -2% | 6.6% |
| EPS | -13.52 | -5.1 | -0.52 | 2.42 |
| % Growth | -165.1% | -880.8% | -121.5% | – |
| EPS Diluted | -13.52 | -5.1 | -0.52 | 1.5 |
| Weighted Avg Shares Out | 12 | 11 | 10 | 10 |
| Weighted Avg Shares Out Dil | 12 | 11 | 10 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $25 | $17 | $16 | $18 |
| Depreciation & Amortization | $27 | $26 | $26 | $27 |
| EBITDA | -$263 | -$73 | $34 | $105 |
| % Margin | -768.2% | -77.8% | 15.3% | 27% |